Literature DB >> 24899993

Intratumoral Heterogeneous F-18 Fluorodeoxyglucose Uptake Corresponds with Glucose Transporter-1 and Ki-67 Expression in a Case of Krukenberg Tumor: Localization of Intratumoral Hypermetabolic Focus by Fused PET/MR Image.

Hyung-Jun Im1, Yong-Il Kim1, Woo Ho Kim2, Seung Hyup Kim3, Keon Wook Kang4.   

Abstract

The expression of glucose transporters (Glut-1, Glut-3), hexokinase-II, and Ki-67 has been proposed to explain intratumoral heterogeneous F-18 fluorodeoxyglucose (FDG) uptake. We report a case of Krukenberg tumor with intratumoral heterogeneous FDG uptake which corresponded well with the expression levels of Glut-1 and ki-67. Fused positron emission tomography (PET)/magnetic resonance (MR) imaging was helpful for localizing the metabolically active area in the tumor specimen. This report elucidates the relationship between the intratumoral heterogeneous FDG uptake and biologic heterogeneity, and shows the usefulness of PET/MR in research on intratumoral heterogeneity.

Entities:  

Keywords:  FDG; Glut-1; Ki-67; Krukenberg tumor; PET/CT; PET/MRI

Year:  2011        PMID: 24899993      PMCID: PMC4043022          DOI: 10.1007/s13139-010-0071-7

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  22 in total

1.  18F-FDG uptake in an ovary containing a hemorrhagic corpus luteal cyst: false-positive PET/CT in a patient with cervical carcinoma.

Authors:  Jennifer Ames; Todd Blodgett; Carolyn Meltzer
Journal:  AJR Am J Roentgenol       Date:  2005-10       Impact factor: 3.959

2.  A look ahead: PET/MR versus PET/CT.

Authors:  Gustav K von Schulthess; Heinz-Peter W Schlemmer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03       Impact factor: 9.236

Review 3.  Non-invasive vascular imaging: assessing tumour vascularity.

Authors:  S Delorme; M V Knopp
Journal:  Eur Radiol       Date:  1998       Impact factor: 5.315

4.  Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers.

Authors:  F Hommura; H Dosaka-Akita; T Mishina; M Nishi; T Kojima; H Hiroumi; S Ogura; M Shimizu; H Katoh; Y Kawakami
Journal:  Clin Cancer Res       Date:  2000-10       Impact factor: 12.531

5.  Dependence of FDG uptake on tumor microenvironment.

Authors:  Andrei Pugachev; Shutian Ruan; Sean Carlin; Steven M Larson; Jose Campa; C Clifton Ling; John L Humm
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-06-01       Impact factor: 7.038

6.  Active and passive mechanisms of [fluorine-18] fluorodeoxyglucose uptake by proliferating and prenecrotic cancer cells in vivo: a microautoradiographic study.

Authors:  R Kubota; K Kubota; S Yamada; M Tada; T Ido; N Tamahashi
Journal:  J Nucl Med       Date:  1994-06       Impact factor: 10.057

7.  Microvessel density: correlation with 18F-FDG uptake and prognostic impact in lung adenocarcinomas.

Authors:  JianFei Guo; Kotaro Higashi; Yoshimichi Ueda; Manabu Oguchi; Tsutomu Takegami; Hirohisa Toga; Tsutomu Sakuma; Hajime Yokota; Shogo Katsuda; Hisao Tonami; Itaru Yamamoto
Journal:  J Nucl Med       Date:  2006-03       Impact factor: 10.057

8.  Angiogenesis in colorectal tumors: microvessel quantitation in adenomas and carcinomas with clinicopathological correlations.

Authors:  P Bossi; G Viale; A K Lee; R Alfano; G Coggi; S Bosari
Journal:  Cancer Res       Date:  1995-11-01       Impact factor: 12.701

9.  The maximum uptake of (18)F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1alpha and GLUT-1 in non-small cell lung cancer.

Authors:  Angela van Baardwijk; Christophe Dooms; Robert Jan van Suylen; Erik Verbeken; Monique Hochstenbag; Cary Dehing-Oberije; Dennis Rupa; Silvia Pastorekova; Sigrid Stroobants; Ulrich Buell; Philippe Lambin; Johan Vansteenkiste; Dirk De Ruysscher
Journal:  Eur J Cancer       Date:  2007-05-23       Impact factor: 9.162

10.  Intratumoral heterogeneity as a confounding factor in clonogenic assays for tumour radioresponsiveness.

Authors:  R A Britten; A J Evans; M J Allalunis-Turner; A J Franko; R G Pearcey
Journal:  Radiother Oncol       Date:  1996-05       Impact factor: 6.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.